Cytomegalovirus seropositivity and aging converge on LILRB1 expression in CD8+ T cells in multiple sclerosis

The human immune system is a vast, adaptable network designed to recognize and neutralize threats, from common colds to dangerous viruses. Among its many soldiers are T cells, a type of white blood cell that patrols the body looking for signs of infection or damage. Sometimes, these cells can become overactive and mistakenly attack the body's own tissues, leading to autoimmune diseases like multiple sclerosis. In this condition, the immune system targets the protective coating of nerves in the brain and spinal cord, causing a wide range of symptoms that vary greatly from person to person. Scientists have long known that the immune system changes as people get older, often becoming less aggressive in its inflammatory responses, which is why multiple sclerosis tends to become less active in later life. At the same time, nearly everyone carries a dormant virus called cytomegalovirus, which hides in the body for a lifetime and subtly reshapes the immune system to keep it in check. The question researchers have been trying to answer is how these two forces—the aging process and the lifelong presence of this virus—interact to influence the behavior of immune cells in people with multiple sclerosis.

A team of researchers from several hospitals in Spain set out to explore this interaction by examining the blood of nearly three hundred patients with multiple sclerosis and fifty healthy individuals. They were particularly interested in a specific marker on the surface of T cells called LILRB1. This marker acts like a brake, sending inhibitory signals that tell a cell to calm down and stop attacking. The scientists wanted to see if the presence of the cytomegalovirus and the age of the patient were linked to how many of these "brake" markers appeared on the T cells, specifically the CD8+ T cells, which are known to be key players in the disease. To do this, they took blood samples from the participants and used a sophisticated laboratory technique that allows scientists to sort through millions of cells and count exactly how many carry specific proteins. They carefully recorded the age, sex, disease history, and current health status of every participant, as well as whether they carried the virus.

The researchers found a clear and distinct pattern in the data. People who carried the cytomegalovirus had a significantly higher proportion of CD8+ T cells displaying the LILRB1 brake marker compared to those who did not carry the virus. This was true for both the patients with multiple sclerosis and the healthy volunteers. The effect was so strong that even after accounting for other factors, the presence of the virus remained a major predictor of this change. Furthermore, the study revealed that age played an independent role. As people got older, the number of these brake-marked cells increased, regardless of whether they had the virus or not. This suggests that the virus and the aging process are two separate roads that lead to the same destination: a T cell population that is more heavily equipped with inhibitory signals.

When the team looked closer at the patients with multiple sclerosis, they noticed that among those who carried the virus, the number of these brake-marked cells was linked to how long the person had been sick and how often they experienced relapses. Specifically, a higher number of these cells was associated with a longer disease duration and a lower rate of relapses. This connection was not seen in patients who did not carry the virus. The researchers also observed that these cells with the brake markers were often the same cells that had lost other surface proteins, a sign that they were highly mature and had been active for a long time. This indicates that the virus drives these cells to become a specific, aged type of immune cell that is less likely to cause inflammation.

Interestingly, the study showed that the changes in T cells were not perfectly synchronized with changes in another type of immune cell called natural killer cells, which also respond to this virus. While the virus causes natural killer cells to change in a well-known way, the changes in T cells appear to be a separate, parallel event. This means the virus is remodeling the immune system in multiple, distinct ways rather than just triggering one single chain reaction. The findings suggest that the lifelong presence of cytomegalovirus may contribute to the natural shift in the immune system that occurs with aging, potentially helping to explain why the inflammatory activity of multiple sclerosis often slows down as people get older. The virus seems to encourage the immune system to adopt a more restrained, less aggressive posture, which could be a protective mechanism against the disease.

The study concludes that the immune landscape of a person with multiple sclerosis is shaped by a convergence of factors, with the virus and aging working together to increase the presence of these calming signals on T cells. While the research does not prove that the virus cures the disease or that these cells are the sole reason for the decline in disease activity, it provides a strong biological link between these factors. It offers a new way to understand how a common, lifelong infection might interact with the natural aging process to influence the course of a complex autoimmune condition. By identifying these specific changes, scientists can better understand the delicate balance between immune defense and immune regulation, opening the door to a deeper comprehension of how the body manages its own defenses over a lifetime.